Literature DB >> 8991013

Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness.

A J de Craen1, P J Roos, A L de Vries, J Kleijnen.   

Abstract

OBJECTIVE: To assess the impact of the colour of a drug's formulation on its perceived effect and its effectiveness and to examine whether antidepressant drugs available in the Netherlands are different in colour from hypnotic, sedative, and anxiolytic drugs.
DESIGN: Systematic review of 12 published studies. Six studies examined the perceived action of different coloured drugs and six the influence of the colour of a drug on its effectiveness. The colours of samples of 49 drugs affecting the central nervous system were assessed using a colour atlas. MAIN OUTCOME MEASURES: Perceived stimulant action versus perceived depressant action of colour of drugs; the trials that assessed the effect of drugs in different colours were done in patients with different diseases and had different outcome measures.
RESULTS: The studies on perceived action of coloured drugs showed that red, yellow, and orange are associated with a stimulant effect, while blue and green are related to a tranquillising effect. The trials that assessed the impact of the colour of drugs on their effectiveness showed inconsistent differences between colours. The quality of the methods of these trials was variable. Hypnotic, sedative, and anxiolytic drugs were more likely than antidepressants to be green, blue, or purple.
CONCLUSIONS: Colours affect the perceived action of a drug and seem to influence the effectiveness of a drug. Moreover, a relation exists between the colouring of drugs that affect the central nervous system and the indications for which they are used. Research contributing to a better understanding of the effect of the colour of drugs is warranted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991013      PMCID: PMC2359128          DOI: 10.1136/bmj.313.7072.1624

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

1.  Accidental poisoning in childhood; an experimental approach to the prevention of poisoning by tablets.

Authors:  H JOLLY; T R FORREST
Journal:  Lancet       Date:  1958-06-21       Impact factor: 79.321

2.  Phenobarbitone poisoning treated with bemegride.

Authors:  A D HURDLE; B K LANE
Journal:  Lancet       Date:  1956-06-02       Impact factor: 79.321

3.  Effect of capsule colour and order of administration of hypnotic treatments.

Authors:  P E Lucchelli; A D Cattaneo; J Zattoni
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

4.  Effect of shape of medication in treatment of anxiety states.

Authors:  M Z Hussain
Journal:  Br J Psychiatry       Date:  1972-05       Impact factor: 9.319

5.  Simple analgesics for arthritis.

Authors:  E C Huskisson
Journal:  Br Med J       Date:  1974-10-26

6.  Demonstration to medical students of placebo responses and non-drug factors.

Authors:  B Blackwell; S S Bloomfield; C R Buncher
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

7.  Classification of placebo drugs: effect of color.

Authors:  K W Jacobs; F M Nordan
Journal:  Percept Mot Skills       Date:  1979-10

Review 8.  Placebo effect in double-blind clinical trials: a review of interactions with medications.

Authors:  J Kleijnen; A J de Craen; J van Everdingen; L Krol
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

9.  Drug expectations associated with perceptual characteristics: ethnic factors.

Authors:  L W Buckalew; K E Coffield
Journal:  Percept Mot Skills       Date:  1982-12

10.  Study on the effects of tablet colour in the treatment of anxiety states.

Authors:  K Schapira; H A McClelland; N R Griffiths; D J Newell
Journal:  Br Med J       Date:  1970-05-23
View more
  42 in total

Review 1.  Statistics notes: blinding in clinical trials and other studies.

Authors:  S J Day; D G Altman
Journal:  BMJ       Date:  2000 Aug 19-26

2.  The Weber-curve pitfall: effects of a forced introduction on reporting rates and reported adverse reaction profiles.

Authors:  Linda de Graaf; Mariette A Fabius; Willem L Diemont; Eugène P van Puijenbroek
Journal:  Pharm World Sci       Date:  2003-12

3.  Are the colors and shapes of current psychotropics designed to maximize the placebo response?

Authors:  Arif Khan; Eswara Prasad Bomminayuni; Amritha Bhat; James Faucett; Walter A Brown
Journal:  Psychopharmacology (Berl)       Date:  2010-05-22       Impact factor: 4.530

4.  The ethics of the placebo in clinical practice.

Authors:  P Lichtenberg; U Heresco-Levy; U Nitzan
Journal:  J Med Ethics       Date:  2004-12       Impact factor: 2.903

5.  Advertisements impact the physiological efficacy of a branded drug.

Authors:  Emir Kamenica; Robert Naclerio; Anup Malani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

6.  Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.

Authors:  F Cremonini; D C Ziogas; H Y Chang; E Kokkotou; J M Kelley; L Conboy; T J Kaptchuk; A J Lembo
Journal:  Aliment Pharmacol Ther       Date:  2010-03-26       Impact factor: 8.171

7.  Behavioral factors in the placebo response.

Authors:  R E Weeks; E Newman
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

8.  Reframing placebo in research and practice.

Authors:  Wayne B Jonas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

9.  The power of placebo.

Authors:  E Ernst; A Herxheimer
Journal:  BMJ       Date:  1996 Dec 21-28

Review 10.  Placebo: misunderstandings and prejudices.

Authors:  Matthias Breidert; Karl Hofbauer
Journal:  Dtsch Arztebl Int       Date:  2009-11-13       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.